Cawachi Limited (TYO:2664)
2,835.00
-19.00 (-0.67%)
Jul 18, 2025, 3:30 PM JST
Cawachi Revenue
In the fiscal year ending March 15, 2025, Cawachi had annual revenue of 287.82B JPY with 0.65% growth. Cawachi had revenue of 70.82B in the quarter ending March 15, 2025, with 0.99% growth.
Revenue
287.82B
Revenue Growth
+0.65%
P/S Ratio
0.22
Revenue / Employee
105.31M
Employees
2,733
Market Cap
63.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 15, 2025 | 287.82B | 1.86B | 0.65% |
Mar 15, 2024 | 285.96B | 4.09B | 1.45% |
Mar 15, 2023 | 281.87B | 2.41B | 0.86% |
Mar 15, 2022 | 279.46B | -5.03B | -1.77% |
Mar 15, 2021 | 284.49B | 14.18B | 5.25% |
Mar 15, 2020 | Pro | Pro | Pro |
Mar 15, 2019 | Pro | Pro | Pro |
Mar 15, 2018 | Pro | Pro | Pro |
Mar 15, 2017 | Pro | Pro | Pro |
Mar 15, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 866.03B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |